Whole Body DWI Sequences As Compared with Standard FDG PET/CT in Patients with Simptomatic Multiple Myeloma
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The primary objective is to evaluate the concordance of FDG PET/CT and total body DWI MRI sequences performed during staging and at the completion of therapy. Specifically, we will assess the positivity rates, both patient-based and lesion-based (total and by district), of the two methods during staging and at the completion of therapy. An interim analysis will be conducted comparing the two methods, followed by a final prognostic analysis.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• • Patients with symptomatic myeloma in the staging phase or with suspected symptomatic myeloma in the diagnostic phase
⁃ Patients who have signed the informed consent form
Locations
Other Locations
Italy
Policlinico S.Orsola Malpighi
RECRUITING
Bologna
Contact Information
Primary
CRISTINA NANNI, MD
cristina.nanni@aosp.bo.it
+390512143182
Time Frame
Start Date: 2022-09-01
Estimated Completion Date: 2027-10-10
Participants
Target number of participants: 83
Treatments
patients with new diagnosis of symptomatic multiple myeloma
fdg pet/CT and Whole body MRI with DWI
Related Therapeutic Areas
Sponsors
Leads: IRCCS Azienda Ospedaliero-Universitaria di Bologna